ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 11395
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 84 I
0194131 EU/1/09/583/074 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 84 I
0194132 EU/1/09/583/075 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 150MG/12,5MG TBL FLM 28 KAL I
0194133 EU/1/09/583/076 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 28 KAL I
0194134 EU/1/09/583/077 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/25MG TBL FLM 28 KAL I
0194135 EU/1/09/583/078 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 28 I
0167305 EU/1/09/583/029 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 30 I
0167306 EU/1/09/583/030 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 56 I
0167307 EU/1/09/583/031 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 60 I
0167308 EU/1/09/583/032 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 90 I
0167309 EU/1/09/583/033 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 98 I
0167310 EU/1/09/583/034 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 100 I
0167311 EU/1/09/583/035 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 50X1 I
0167312 EU/1/09/583/036 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 7 II
0167313 EU/1/09/583/037 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 14 II
0167314 EU/1/09/583/038 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 15 II
0167315 EU/1/09/583/039 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 20 II
0167316 EU/1/09/583/040 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 28 II
0167317 EU/1/09/583/041 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 30 II
0167318 EU/1/09/583/042 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN/HYDROCHLOROTHIAZID TEVA 300MG/12,5MG TBL FLM 56 II
0167319 EU/1/09/583/043 irbesartan.pdf irbesartan.pdf C09DA04 R

‹‹ ‹ 100 180 190 200 210 220 225 226 227 228 229 230 231 232 233 234 235 240 250 260 270 280 300 400 500 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 1. February 2023 at 00:09
Last update of price and payment data: 1. February 2023 at 00:09